Shanghai Henlius Biotech, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 34 7 91 588 1,682 3,215 5,395 5,724
Przychód Δ r/r 0.0% -78.1% 1125.3% 546.2% 186.3% 91.1% 67.8% 6.1%
Marża brutto 55.7% 27.3% 21.0% 69.0% 68.9% 73.7% 72.6% 73.1%
EBIT (mln) -325 -457 -821 -950 -872 -587 632 939
EBIT Δ r/r 0.0% 40.5% 79.9% 15.7% -8.2% -32.7% -207.7% 48.7%
EBIT (%) -958.3% -6151.8% -903.1% -161.7% -51.8% -18.2% 11.7% 16.4%
Koszty finansowe (mln) 55 58 48 44 85 106 111 123
EBITDA (mln) -298 -399 -739 -814 -672 -309 911 1,146
EBITDA(%) -879.5% -5381.4% -812.4% -138.5% -39.9% -9.6% 16.9% 20.0%
Podatek (mln) 4 5 1 44 27 1 24 25
Zysk Netto (mln) -271 -494 -875 -1,037 -984 -695 546 820
Zysk netto Δ r/r 0.0% 82.5% 77.3% 18.5% -5.1% -29.3% -178.5% 50.3%
Zysk netto (%) -797.9% -6652.6% -962.8% -176.5% -58.5% -21.6% 10.1% 14.3%
EPS -0.5 -0.95 -1.76 -1.96 -1.83 -1.28 1.0 1.51
EPS (rozwodnione) -0.5 -0.92 -1.76 -1.96 -1.83 -1.28 1.0 1.51
Ilośc akcji (mln) 539 521 497 528 538 542 546 543
Ważona ilośc akcji (mln) 539 539 497 530 539 542 543 543
Waluta CNY CNY CNY CNY CNY CNY CNY CNY